Centennial Wealth Advisory LLC acquired a new position in shares of Exelon Corporation (NASDAQ:EXC - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 10,481 shares of the company's stock, valued at approximately $455,000.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Hazlett Burt & Watson Inc. increased its holdings in shares of Exelon by 46.4% in the 1st quarter. Hazlett Burt & Watson Inc. now owns 694 shares of the company's stock valued at $32,000 after acquiring an additional 220 shares during the period. ANTIPODES PARTNERS Ltd purchased a new stake in shares of Exelon during the 1st quarter worth $34,000. Investment Research & Advisory Group Inc. purchased a new stake in shares of Exelon during the 2nd quarter worth $39,000. MJT & Associates Financial Advisory Group Inc. purchased a new stake in shares of Exelon in the 1st quarter worth about $42,000. Finally, Opal Wealth Advisors LLC purchased a new stake in shares of Exelon in the 1st quarter worth about $50,000. Institutional investors and hedge funds own 80.92% of the company's stock.
Wall Street Analysts Forecast Growth
EXC has been the topic of several recent research reports. UBS Group reiterated a "neutral" rating and issued a $48.00 price objective (up from $47.00) on shares of Exelon in a research report on Friday, July 11th. Morgan Stanley reduced their target price on shares of Exelon from $50.00 to $49.00 and set an "equal weight" rating on the stock in a report on Thursday, September 25th. Finally, KeyCorp reduced their target price on shares of Exelon from $39.00 to $37.00 and set an "underweight" rating on the stock in a report on Wednesday, July 16th. Three analysts have rated the stock with a Buy rating, five have given a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and a consensus price target of $47.44.
Read Our Latest Report on Exelon
Exelon Stock Up 0.4%
EXC opened at $44.27 on Tuesday. The firm has a 50 day moving average price of $44.09 and a 200 day moving average price of $44.21. The company has a market cap of $44.71 billion, a PE ratio of 16.83, a price-to-earnings-growth ratio of 2.59 and a beta of 0.41. Exelon Corporation has a 1 year low of $35.94 and a 1 year high of $48.11. The company has a debt-to-equity ratio of 1.66, a quick ratio of 0.85 and a current ratio of 0.95.
Exelon (NASDAQ:EXC - Get Free Report) last posted its earnings results on Thursday, July 31st. The company reported $0.39 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.37 by $0.02. The firm had revenue of $5.43 billion during the quarter, compared to the consensus estimate of $5.47 billion. Exelon had a net margin of 11.16% and a return on equity of 9.85%. The company's revenue was up 1.2% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.47 EPS. Exelon has set its FY 2025 guidance at 2.640-2.740 EPS. Sell-side analysts expect that Exelon Corporation will post 2.64 earnings per share for the current year.
Exelon Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Monday, September 15th. Investors of record on Monday, August 11th were given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 3.6%. The ex-dividend date of this dividend was Monday, August 11th. Exelon's dividend payout ratio is 60.84%.
Exelon Company Profile
(
Free Report)
Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Exelon, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exelon wasn't on the list.
While Exelon currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.